Breast cancer accumulates Foxp3+ Treg cells upon tumor progression, and we have demonstrated that transient ablation of Treg cells in established, highly immuno-suppressive breast tumors results in a significant increase in anti-tumor immunity in primary and metastatic tumors (10). Here, FOXP3 is linked to neoplasm.